THE NATIONAL PRION MONITORING COHORT: A LONGITUDINAL OBSERVATIONAL STUDY OF UK HUMAN PRION INFECTION by Mead, S, Gajulapalli, D, Walker, S, Wroe, S, Rudge, P, Collinge, J

Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease. by Rossi, M, Mead, S, Collinge, J, Rudge, P, Vincent, A

Creutzfeld-Jakob disease--reply. by Angus-Leppan, H, Rudge, P, Mead, S, Collinge, J, Vincent, A

Autoantibodies in sporadic Creutzfeldt-Jakob disease. by Angus-Leppan, H, Rudge, P, Mead, S, Collinge, J, Vincent, A

Clinical trials and methodological problems in prion diseases Reply by Mead, S, Rudge, P, Hudson, F, Walker, S, Darbyshire, J, Collinge, J, Investigators, P-1

Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. by Irani, SR, Buckley, C, Vincent, A, Cockerell, O, Rudge, P, Johnson, MR, Smith, S

Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients. by Calder, V, Bellamy, A, Owen, S, Lewis, C, Rudge, P, Davison, A, Feldmann, M

ANALYSIS OF EIGHT RATING SCALES SUPPORTS THE USE OF FUNCTIONAL OUTCOME MEASURES IN PRION DISEASE CLINICAL TRIALS: EXPERIENCE FROM THE PRION-1 TRIAL AND THE NATIONAL PRION MONITORIN... by Thompson, A, Rudge, P, Wroe, S, Mead, S, Darbyshire, J, MacKay, A, Ranopa, M, Collinge, J, Gopalakrishnan, G, Walker, S

Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. by Cruickshank, J, Richardson, J, Morgan, O, Porter, J, Klenerman, P, Knight, J, Newell, A, Rudge, P, Dalgleish, A

Analysis of Eight Rating Scales Supports the use of Functional Outcome Measures in Prion Disease Clinical Trials: Experience from the PRION-1 trial and the National Prion Monitorin... by Mead, S, Thompson, A, Gopalakrishnan, G, Ranopa, M, Rudge, P, Wroe, S, Hudson, F, MacKay, A, Darbyshire, J, Collinge, J, Walker, S

Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1. by Carswell, C, Rañopa, M, Pal, S, Macfarlane, R, Siddique, D, Thomas, D, Webb, T, Wroe, S, Walker, S, Darbyshire, J, Collinge, J, Mead, S, Rudge, P

Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases. by Siddique, D, Hyare, H, Wroe, S, Webb, T, Macfarlane, R, Rudge, P, Collinge, J, Powell, C, Brandner, S, So, P, Walker, S, Mead, S, Yousry, T, Thornton, J

The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. by Thompson, A, Lowe, J, Fox, Z, Lukic, A, Porter, M, Ford, L, Gorham, M, Gopalakrishnan, G, Rudge, P, Walker, A, Collinge, J, Mead, S

PRION-1 scales analysis supports use of functional outcome measures in prion disease. by Mead, S, Ranopa, M, Gopalakrishnan, G, Thompson, A, Rudge, P, Wroe, S, Kennedy, A, Hudson, F, MacKay, A, Darbyshire, J, Collinge, J, Walker, A

Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study by De Vita, E, Ridgway, G, White, M, Porter, M, Caine, D, Rudge, P, Collinge, J, Yousry, T, Jager, H, Mead, S, Thornton, J, Hyare, H

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. by Barnes, D, Hughes, R, Morris, R, Wade-Jones, O, Brown, P, Britton, T, Francis, D, Perkin, G, Rudge, P, Swash, M, Katifi, H, Farmer, S, Frankel, J

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. by Collinge, J, Gorham, M, Hudson, F, Kennedy, A, Keogh, G, Pal, S, Rossor, M, Rudge, P, Siddique, D, Spyer, M, Thomas, D, Walker, S, Webb, T, Wroe, S, Darbyshire, J

The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis. by Sharrack, B, Hughes, R, Morris, R, Soudain, S, Wade-Jones, O, Barnes, D, Brown, P, Britton, T, Francis, D, Perkin, G, Rudge, P, Swash, M, Katifi, H, Farmer, S, Frankel, J

Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob disease by Mead, S, Burnell, M, Lowe, J, Thompson, A, Lukic, A, Porter, M, Carswell, C, Kaski, D, Kenny, J, Mok, T, Bjurstrom, N, Franko, E, Gorham, M, Druyeh, R, Wadsworth, J, Jaunmuktane, Z, Brandner, S, Hyare, H, Rudge, P, Walker, A, Collinge, J